141 related articles for article (PubMed ID: 22281375)
1. "PancPro" as a tool for selecting families eligible for pancreatic cancer screening: an Italian study of incident cases.
Leonardi G; Marchi S; Falconi M; Zerbi A; Ussia V; de Bortoli N; Mosca F; Presciuttini S; Del Chiaro M
Dig Liver Dis; 2012 Jul; 44(7):585-8. PubMed ID: 22281375
[TBL] [Abstract][Full Text] [Related]
2. Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma.
Del Chiaro M; Zerbi A; Falconi M; Bertacca L; Polese M; Sartori N; Boggi U; Casari G; Longoni BM; Salvia R; Caligo MA; Di Carlo V; Pederzoli P; Presciuttini S; Mosca F
Pancreatology; 2007; 7(5-6):459-69. PubMed ID: 17912010
[TBL] [Abstract][Full Text] [Related]
3. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.
Langer P; Kann PH; Fendrich V; Habbe N; Schneider M; Sina M; Slater EP; Heverhagen JT; Gress TM; Rothmund M; Bartsch DK
Gut; 2009 Oct; 58(10):1410-8. PubMed ID: 19470496
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer.
Tersmette AC; Petersen GM; Offerhaus GJ; Falatko FC; Brune KA; Goggins M; Rozenblum E; Wilentz RE; Yeo CJ; Cameron JL; Kern SE; Hruban RH
Clin Cancer Res; 2001 Mar; 7(3):738-44. PubMed ID: 11297271
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic carcinoma surveillance in patients with familial melanoma.
Parker JF; Florell SR; Alexander A; DiSario JA; Shami PJ; Leachman SA
Arch Dermatol; 2003 Aug; 139(8):1019-25. PubMed ID: 12925390
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
7. PancPRO: risk assessment for individuals with a family history of pancreatic cancer.
Wang W; Chen S; Brune KA; Hruban RH; Parmigiani G; Klein AP
J Clin Oncol; 2007 Apr; 25(11):1417-22. PubMed ID: 17416862
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic cancer surveillance: learning as we go.
Brentnall TA
Am J Gastroenterol; 2011 May; 106(5):955-6. PubMed ID: 21540900
[TBL] [Abstract][Full Text] [Related]
9. [Strategies for screening for pancreatic adenocarcinoma in high-risk patients].
Béchade D
Bull Cancer; 2011 Jul; 98(7):827-36. PubMed ID: 21684836
[TBL] [Abstract][Full Text] [Related]
10. Selecting families eligible for pancreatic cancer screening: another brick in the wall for the early detection of pancreatic ductal adenocarcinoma and its precursors.
Pezzilli R; Morselli-Labate AM
Dig Liver Dis; 2012 Jul; 44(7):539-40. PubMed ID: 22561444
[No Abstract] [Full Text] [Related]
11. [Familial pancreatic cancer--concept for study of the National Case Collection and early diagnosis program for high risk people].
Gerdes B; Kress R; Rieder H; Sina-Frey M; Przypadlo E; Barth P; Rehder H; Hahn SA; Schmiegel W; Rothmund M; Ziegler A; Bartsch DK
Z Arztl Fortbild Qualitatssich; 2002 May; 96(4):251-5. PubMed ID: 12068743
[TBL] [Abstract][Full Text] [Related]
12. Genotype/phenotype of familial pancreatic cancer.
Brand RE; Lynch HT
Endocrinol Metab Clin North Am; 2006 Jun; 35(2):405-15, xi. PubMed ID: 16632102
[TBL] [Abstract][Full Text] [Related]
13. [Familial neoplasms: investigation of genealogic trees of patients surgically treated for colonic adenocarcinoma].
Caroti Ghelli C; Presciuttini S; Scarcello E; Vannucci L; Mosca F
Ann Ital Chir; 1994; 65(5):517-26. PubMed ID: 7733573
[TBL] [Abstract][Full Text] [Related]
14. Strategies for screening for pancreatic adenocarcinoma in high-risk patients.
Canto MI
Semin Oncol; 2007 Aug; 34(4):295-302. PubMed ID: 17674957
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation.
Vasen HF; Wasser M; van Mil A; Tollenaar RA; Konstantinovski M; Gruis NA; Bergman W; Hes FJ; Hommes DW; Offerhaus GJ; Morreau H; Bonsing BA; de Vos tot Nederveen Cappel WH
Gastroenterology; 2011 Mar; 140(3):850-6. PubMed ID: 21129377
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a major gene influencing risk of pancreatic cancer.
Klein AP; Beaty TH; Bailey-Wilson JE; Brune KA; Hruban RH; Petersen GM
Genet Epidemiol; 2002 Aug; 23(2):133-49. PubMed ID: 12214307
[TBL] [Abstract][Full Text] [Related]
17. CDKN2A is the main susceptibility gene in Italian pancreatic cancer families.
Ghiorzo P; Fornarini G; Sciallero S; Battistuzzi L; Belli F; Bernard L; Bonelli L; Borgonovo G; Bruno W; De Cian F; Decensi A; Filauro M; Faravelli F; Gozza A; Gargiulo S; Mariette F; Nasti S; Pastorino L; Queirolo P; Savarino V; Varesco L; Scarrà GB;
J Med Genet; 2012 Mar; 49(3):164-70. PubMed ID: 22368299
[TBL] [Abstract][Full Text] [Related]
18. Hereditary pancreatic cancer: a clinical perspective.
Greer JB; Lynch HT; Brand RE
Best Pract Res Clin Gastroenterol; 2009; 23(2):159-70. PubMed ID: 19414143
[TBL] [Abstract][Full Text] [Related]
19. Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
Duell EJ; Casella DP; Burk RD; Kelsey KT; Holly EA
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):726-31. PubMed ID: 16614115
[TBL] [Abstract][Full Text] [Related]
20. Colonoscopic findings in first-degree relatives of patients with colorectal cancer: a population-based screening program.
Armelao F; Paternolli C; Franceschini G; Franch R; Orlandi PG; Miori G; Avancini I; Togni M; Rossi M; Meggio A; Tasini E; Manfrini R; Giacomin D; Fasoli R; Faitini K; Mastromauro M; Costa S; Ridolfi F; Rosi P; de Pretis G
Gastrointest Endosc; 2011 Mar; 73(3):527-534.e2. PubMed ID: 21353850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
